Market Place
Sourcing Support
Biogen pays $900M to resolve whistleblower`s kickbacks suit
21 Jul 2022 //
FIERCEPHARMA
Abarca Details First Value-Based Agreement For Medicaid Members Biogen
20 Oct 2020 //
PRNEWSWIRE
EMD Serono to Showcase New Data at ACTRIMS-ECTRIMS MSVirtual2020
03 Sep 2020 //
PRNEWSWIRE
Merck says it has agreed to supply potential COVID-19 drug Rebif to EU countries
09 Jul 2020 //
REUTERS
Rebif® U.S. Label Now Includes Pregnancy Outcomes and Lactation Information
27 May 2020 //
PRNEWSWIRE
Biogen`s Plegridy (Interferon Beta-1A) Receives Supplemental Approval In US
31 Mar 2020 //
FDA
Merck KGaA donates multiple sclerosis med Rebif to French COVID-19 trial
23 Mar 2020 //
FIERCE PHARMA
Merck KGaA donates aging MS med Rebif to French COVID-19 trial
21 Mar 2020 //
FIERCE PHARMA
Biogen`s Avonex (Interferon Beta-1A) Receives Supplemental Approval In US
16 Jul 2019 //
FDA
Analysts focus on Alzheimer`s as Biogen`s Spinraza zooms ahead
25 Jul 2018 //
FIERCEPHARMA
Enforcement Report - Week of May 16, 2018
16 May 2018 //
FDA
Biogen set to raise $300M from New Year`s price hikes
03 Jan 2018 //
FIERCE PHARMA
Novartis’ Extavia evades NICE restrictions on MS drugs
21 Dec 2017 //
PMLIVE
NICE recommends Novartis` Extavia for MS, but knocks back a raft
20 Dec 2017 //
PHARMAFILE
Bayer Receives FDA Approval of myBETAapp and BETACONNECT Navigator
31 May 2017 //
BIOSPECTRUM
Biogen Reveals Federal Investigation Into Pricing, Rebate Payments
04 Feb 2017 //
THE STREET
Biogen joins peers in federal probe of patient assistance programs
03 Feb 2017 //
FIERCE PHARMA
Bayer Announces FDA Acceptance of myBETAapp™ & BETACONNECT™ Navigator
14 Dec 2016 //
PR NEWSWIRE
Study By Spherix Global Insight Indicate Therapy Switching Rates For MS Patients
15 Apr 2016 //
PR NEWSWIRE
EMD Serono Takes on Exclusive Promotion of Rebif(interferon beta-1a) in the US
19 Jan 2016 //
PR NEWS WIRE
Promise Of High Prices Now Driving Biopharma R&D Investments
05 Jan 2016 //
FORBES
Merck KGaA rolls out big plans for expansion in Africa
21 Nov 2015 //
FIERCE PHARMA
Merck KGaA Raises Forecast as Quarterly Profit Tops Estimate
12 Nov 2015 //
BLOOMBERG
Biogen making risky shift to Alzheimer’s drugs
12 Nov 2015 //
BOSTON GLOBE
Merck KGaA counts on Latin America to power consumer-health future
30 Sep 2015 //
FIERCE PHARMA
New Rebif® Data at ECTRIMS Highlights the Importance of Disability and Imaging…
24 Sep 2015 //
PR NEWS WIRE
How Much Would You Pay for an Old Drug? If You Have MS, a Fortune
25 Apr 2015 //
BLOOMBERG BUSINESS
Merck`s Rebif Held Its Own In Last Year`s MS Market Shakeup. What About 2015?
03 Mar 2015 //
FIERCE PHARMA
Biogen Idec Plans Phase III Alzheimer`s Trial Before Year-End
30 Jan 2015 //
PMLIVE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.